ScopeSys Inc.
1 known investors
ScopeSys develops single-molecule imaging technology, called Convex Lens-induced Confinement (CLiC), that enables high-throughput measurements with single-molecule resolution for genomic-medicine drug development. Its platform helps developers of RNA, DNA, and nanoparticle-delivered drugs analyze single-molecule interactions to optimize therapeutic sequences and mRNA lipid nanoparticle formulations.
BiotechDeep TechHealthtech